<VariationArchive VariationID="1339664" VariationName="NM_001164508.2(NEB):c.20975_20976del (p.Lys6992fs)" VariationType="Deletion" Accession="VCV001339664" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-02-12" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1330875" VariationID="1339664">
      <GeneList>
        <Gene Symbol="NEB" FullName="nebulin" GeneID="4703" HGNC_ID="HGNC:7720" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151485339" stop="151734476" display_start="151485339" display_stop="151734476" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152341852" stop="152591000" display_start="152341852" display_stop="152591000" Strand="-" />
          </Location>
          <OMIM>161650</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001164508.2(NEB):c.20975_20976del (p.Lys6992fs)</Name>
      <CanonicalSPDI>NC_000002.12:151538160:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="151538161" stop="151538162" display_start="151538161" display_stop="151538162" variantLength="2" positionVCF="151538160" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="152394675" stop="152394676" display_start="152394675" display_stop="152394676" variantLength="2" positionVCF="152394674" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K5291fs</ProteinChange>
      <ProteinChange>K6992fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.152394676_152394677del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.152394676_152394677del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.151538162_151538163del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.151538162_151538163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009382.2" sequenceAccession="NG_009382" sequenceVersion="2" change="g.201326_201327del">
            <Expression>NG_009382.2:g.201326_201327del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164507.2" sequenceAccession="NM_001164507" sequenceVersion="2" change="c.20975_20976del" MANEPlusClinical="true">
            <Expression>NM_001164507.2:c.20975_20976del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157979.2" sequenceAccession="NP_001157979" sequenceVersion="2" change="p.Lys6992fs">
            <Expression>NP_001157979.2:p.Lys6992fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164508.2" sequenceAccession="NM_001164508" sequenceVersion="2" change="c.20975_20976del" MANESelect="true">
            <Expression>NM_001164508.2:c.20975_20976del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001157980.2" sequenceAccession="NP_001157980" sequenceVersion="2" change="p.Lys6992fs">
            <Expression>NP_001157980.2:p.Lys6992fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271208.2" sequenceAccession="NM_001271208" sequenceVersion="2" change="c.20975_20976del">
            <Expression>NM_001271208.2:c.20975_20976del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258137.2" sequenceAccession="NP_001258137" sequenceVersion="2" change="p.Lys6992fs">
            <Expression>NP_001258137.2:p.Lys6992fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004543.5" sequenceAccession="NM_004543" sequenceVersion="5" change="c.15872_15873del">
            <Expression>NM_004543.5:c.15872_15873del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004534.3" sequenceAccession="NP_004534" sequenceVersion="3" change="p.Lys5291fs">
            <Expression>NP_004534.3:p.Lys5291fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_202" sequenceAccession="LRG_202">
            <Expression>LRG_202:g.201326_201327del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_202t1" sequenceAccession="LRG_202t1">
            <Expression>LRG_202t1:c.20975_20976del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1559680233" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001164508.2(NEB):c.20975_20976del (p.Lys6992fs) AND Nemaline myopathy" Accession="RCV001825052" Version="1">
        <ClassifiedConditionList TraitSetID="12233">
          <ClassifiedCondition DB="MedGen" ID="C0206157">Nemaline myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001164508.2(NEB):c.20975_20976del (p.Lys6992fs) AND Nemaline myopathy 2" Accession="RCV003514532" Version="1">
        <ClassifiedConditionList TraitSetID="3882">
          <ClassifiedCondition DB="MedGen" ID="C1850569">Nemaline myopathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-02-12" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16917880</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25205138</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="12233" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9537" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Rod myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathies, Nemaline</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy</ElementValue>
                <XRef ID="MONDO:0018958" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
                <XRef ID="75072002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12033" />
                <XRef ID="12033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="607" DB="Orphanet" />
              <XRef ID="C0206157" DB="MedGen" />
              <XRef ID="MONDO:0018958" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS161800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3882" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5618" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy 2, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nemaline myopathy caused by mutation in the nebulin gene</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nemaline myopathy 2</ElementValue>
                <XRef ID="Nemaline+myopathy+2/5124" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009725" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEM2</ElementValue>
                <XRef Type="MIM" ID="256030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15209" />
                <XRef ID="15209" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22510848</ID>
              </Citation>
              <XRef ID="C1850569" DB="MedGen" />
              <XRef ID="MONDO:0009725" DB="MONDO" />
              <XRef Type="MIM" ID="256030" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4065178" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-12" DateCreated="2022-02-12">
        <ClinVarSubmissionID localKey="NM_001271208.1:c.20975_20976delAA|MedGen:C0206157" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002074158" DateUpdated="2022-02-12" DateCreated="2022-02-12" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16917880</ID>
          </Citation>
          <Comment>Variant summary: NEB c.20975_20976delAA (p.Lys6992SerfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 248438 control chromosomes. c.20975_20976delAA has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with Nemaline Myopathy 2 (example, Lehtokari_2006). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001271208.1:c.20975_20976delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0206157" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11058952</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7978280" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4833645|MedGen:C1850569" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004293397" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16917880</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25205138</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1339664). This variant is also known as g.194994_194995delAA(p.Lys5291fs). This premature translational stop signal has been observed in individual(s) with nemaline myopathy (PMID: 16917880). This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Lys6992Serfs*4) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NEB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.152394675_152394676del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850569" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7978280" TraitType="Disease" MappingType="XRef" MappingValue="C1850569" MappingRef="MedGen">
        <MedGen CUI="C1850569" Name="Nemaline myopathy 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4065178" TraitType="Disease" MappingType="XRef" MappingValue="C0206157" MappingRef="MedGen">
        <MedGen CUI="C0206157" Name="Nemaline myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

